Novel 7-deazapurine nucleosides for therapeutic uses
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F17%3A00520816" target="_blank" >RIV/61388963:_____/17:00520816 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=AU&NR=2015205885B2&KC=B2&FT=D&ND=4&date=20170406&DB=&locale=en_EP#" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?CC=AU&NR=2015205885B2&KC=B2&FT=D&ND=4&date=20170406&DB=&locale=en_EP#</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Novel 7-deazapurine nucleosides for therapeutic uses
Original language description
The invention provides compounds of formula I, wherein R1, R 2 and R 3 have values defined in the specification and a pharmaceutically acceptable salt thereof, or an optical isomer thereof, or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
10401 - Organic chemistry
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
AU2015205885
Publisher
AU001 -
Publisher name
IP Australia
Place of publication
Phillip ACT
Publication country
AU - AUSTRALIA
Date of acceptance
Apr 6, 2017
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence